Under the stewardship of regenerative medicine industry veteran BG Rhee, Korean firm SCM Lifescience has engaged in several global M&A deals in…

South Korea is the 12th largest healthcare market globally with a market size of around USD 20 billion in 2019. With the government’s plans to…

Dr BG Rhee, CEO of SCM Lifescience discusses their patented proprietary subfraction technology to extract high purity cell cultures, and the impact…